Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Metabolic medicine

Treating MADD: Nutrition, Supplements, and Daily Life

At a Glance

MADD is managed by preventing fasting and the body’s breakdown of its own tissues through individualized nutrition, frequent meals, and specialist-directed supplements such as riboflavin. L-carnitine or CoQ10 may be used selectively, with ongoing monitoring.

Managing Multiple acyl-CoA dehydrogenase deficiency (MADD) is a lifelong commitment focused on one primary goal: preventing catabolism (when the body breaks itself down for energy) [1]. Treatment involves an individualized combination of dietary targets and supplements to help your metabolism function as smoothly as possible [2][3].

The Foundation: Individualized Dietary Management

The core of MADD management often includes adjusting the intake of fats and proteins while emphasizing carbohydrates [2]. However, you must never self-restrict or completely eliminate fats and proteins from your diet. Your body still requires adequate calories, essential fatty acids, and protein to grow and maintain muscle health [3].

  • Customized Targets: A metabolic dietitian will prescribe exact targets for fat, protein, and carbohydrates based on your age, specific phenotype, and residual enzyme function. Over-restriction can cause dangerous malnutrition and growth problems.
  • Frequent Meals: To prevent the body from entering a fasting state, you must eat small, frequent meals throughout the day and sometimes even during the night [2].
  • No Prolonged Fasting: Fasting forces the body to burn its own fat stores for energy—which a person with MADD cannot do safely [4][1]. Your metabolic team will provide a specific schedule for how long you can safely go between meals.

Important Note: The strict restrictions you might undergo during an acute hospital crisis (like halting IV lipids) are completely different from your long-term, daily nutritional needs.

Riboflavin (Vitamin B2)

Riboflavin is a central treatment for many patients with MADD, particularly those with the late-onset (Type III) form [2].

Riboflavin is a precursor to FAD, a molecule that acts like a “helper” for the enzymes involved in energy transfer [3]. In many cases, providing the body with high doses of riboflavin—under a doctor’s supervision—can help stabilize the enzymes and restore function [3][5].

  • The Trial Period: Your doctor will prescribe a specific dose and monitor you to see if you have a “riboflavin response.” While many late-onset patients see improvement in muscle strength and energy, response is highly variable [6][7].
  • Not a Universal Cure: Some people are “non-responders,” and those with more severe neonatal forms (Types I and II) may see less benefit [8][4].
  • Do Not Self-Dose: Never self-dose or stop your other preventative measures just because you feel better. Feeling better does not mean the underlying metabolic risk has disappeared [5].

Adjunct Supplements

Your metabolic team may also prescribe other supplements based on your specific lab results and clinical indications.

L-Carnitine

Carnitine acts like a metabolic shuttle. It helps transport fatty acids and binds to organic acids so they can be flushed out of the body [9]. Because people with MADD often have very low carnitine levels, specialists generally prescribe L-carnitine when a deficiency is documented or clinically indicated [10].

Coenzyme Q10 (CoQ10)

CoQ10 is another link in the mitochondrial energy chain. While the defect in MADD affects the pathway that feeds into the “Q-pool,” the evidence for CoQ10 supplementation is currently limited mostly to cell studies and individual case reports [11][12]. It is an optional, specialist-directed adjunct with uncertain clinical benefit, and it requires metabolic-team supervision [13][14].

Monitoring and Coordination

Treatment for MADD is highly individualized. What works for one person may not be appropriate for another. You will need to work closely with your metabolic team to:

  • Adjust your diet and supplements during times of growth, pregnancy, or increased physical activity [15][16].
  • Ensure that you are maintaining a healthy weight and normal growth while on a modified diet [2][17].

Common questions in this guide

How should someone with MADD eat each day?
Most people with MADD need small, frequent meals and a schedule set by their metabolic team so they do not enter a fasting state. The right amounts of carbohydrate, fat, and protein depend on age, the specific form of MADD, and remaining enzyme function, so a metabolic dietitian should set the targets. Do not remove fats or proteins without medical guidance.
Why is prolonged fasting dangerous for people with MADD?
Prolonged fasting makes the body use stored fat and break down its own tissues for energy. People with MADD may not be able to process fat safely, so fasting can lead to dangerous catabolism, or metabolic breakdown. Follow the maximum fasting interval provided by the metabolic team, including overnight.
Does riboflavin help everyone with MADD?
Riboflavin can improve energy production for some people with MADD, particularly those with late-onset Type III disease, but it does not work for everyone. A doctor should prescribe a trial and monitor the response; feeling better does not remove the need for the rest of the treatment plan.
When might L-carnitine or CoQ10 be used for MADD?
L-carnitine may be prescribed when blood levels are low or there is another clinical reason to use it. CoQ10 is an optional specialist-directed supplement because evidence of benefit in MADD is limited. Neither supplement should be started or changed without the metabolic team's guidance.
How are MADD nutrition needs monitored over time?
The metabolic team may adjust food and supplement targets during growth, pregnancy, or increased physical activity. They also monitor weight, growth, nutrition, and relevant laboratory results to reduce the risk of undernutrition or over-restriction. Bring changes in energy, muscle strength, or exercise tolerance to the team's attention.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Multiple acyl-CoA dehydrogenase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are the maximum fasting intervals I/my child can safely tolerate during the day and overnight?
  2. 2.Given my/my child's specific genetic mutation, how likely is it that we will see a significant response to riboflavin?
  3. 3.How should our dietary targets for protein and fat change as I/my child gets older or becomes more physically active?
  4. 4.How long should we trial riboflavin before deciding whether it is working or if the dose needs to be adjusted?
  5. 5.Are there specific markers you monitor to ensure we are not over-restricting fats and proteins?

References

References (17)
  1. 1

    Glutaric acidemia type 2 presenting as a surgical acute abdomen: a case of unnecessary exploratory laparotomy in an adult.

    Bilal PK, Erkoç SK, Polat B, et al.

    Archive of clinical cases 2026; (13(3)):108-111 doi:10.22551/2026.52.1303.10350.

    PMID: 42751163
  2. 2

    Management of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in Pregnancy.

    Shear MA, LaTray A, Chang IJ, et al.

    Metabolites 2025; (15(7)) doi:10.3390/metabo15070432.

    PMID: 40710532
  3. 3

    ETF dehydrogenase advances in molecular genetics and impact on treatment.

    Missaglia S, Tavian D, Angelini C

    Critical reviews in biochemistry and molecular biology 2021; (56(4)):360-372 doi:10.1080/10409238.2021.1908952.

    PMID: 33823724
  4. 4

    Late-onset multiple acyl-CoA dehydrogenase deficiency: an insidious presentation.

    Rao NN, Burns K, Manolikos C, Hodge S

    BMJ case reports 2023; (16(5)) doi:10.1136/bcr-2022-252668.

    PMID: 37217231
  5. 5

    Clinical, pathological and genetic features and follow-up of 110 patients with late-onset MADD: a single-center retrospective study.

    Wen B, Tang S, Lv X, et al.

    Human molecular genetics 2022; (31(7)):1115-1129 doi:10.1093/hmg/ddab308.

    PMID: 34718578
  6. 6

    Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects.

    Lupica A, Oteri R, Volta S, et al.

    Frontiers in neurology 2022; (13()):815523 doi:10.3389/fneur.2022.815523.

    PMID: 35309592
  7. 7

    A Historical Cohort Study on the Efficacy of Glucocorticoids and Riboflavin Among Patients with Late-onset Multiple Acyl-CoA Dehydrogenase Deficiency.

    Liu XY, Wang ZQ, Wang DN, et al.

    Chinese medical journal 2016; (129(2)):142-6 doi:10.4103/0366-6999.173438.

    PMID: 26830983
  8. 8

    A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency.

    van der Westhuizen FH, Smuts I, Honey E, et al.

    Journal of the neurological sciences 2018; (384()):121-125 doi:10.1016/j.jns.2017.11.012.

    PMID: 29249369
  9. 9

    A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene.

    Chautard R, Laroche-Raynaud C, Lia AS, et al.

    BMC medical genomics 2020; (13(1)):12 doi:10.1186/s12920-020-0665-6.

    PMID: 31996215
  10. 10

    Multiple acyl-CoA dehydrogenation deficiency as decreased acyl-carnitine profile in serum.

    Wen B, Li D, Li W, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2015; (36(6)):853-9 doi:10.1007/s10072-015-2197-y.

    PMID: 25827849
  11. 11

    Coenzyme Q10 serves to couple mitochondrial oxidative phosphorylation and fatty acid β-oxidation, and attenuates NLRP3 inflammasome activation.

    Chokchaiwong S, Kuo YT, Lin SH, et al.

    Free radical research 2018; (52(11-12)):1445-1455 doi:10.1080/10715762.2018.1500695.

    PMID: 30003820
  12. 12

    Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2.

    Xiao C, Astiazaran-Symonds E, Basu S, et al.

    American journal of medical genetics. Part A 2020; (182(10)):2426-2431 doi:10.1002/ajmg.a.61786.

    PMID: 32804429
  13. 13

    Exposure to sertraline and ranolazine is common among adult patients with genetically uncharacterized lipid storage myopathy.

    Jones FJS, Mirman I, Milone M, Liewluck T

    Journal of the neurological sciences 2025; (475()):123599 doi:10.1016/j.jns.2025.123599.

    PMID: 40602075
  14. 14

    Long-term outcomes of a patient with late-onset multiple acyl-CoA dehydrogenase deficiency caused by novel mutations in ETFDH: A case report.

    Wang J, Wu JC, Yu XE, et al.

    Medicine 2018; (97(48)):e13153 doi:10.1097/MD.0000000000013153.

    PMID: 30508893
  15. 15

    Successful Pregnancy in a Young Woman with Multiple Acyl-CoA Dehydrogenase Deficiency.

    Creanza A, Cotugno M, Mazzaccara C, et al.

    JIMD reports 2018; (39()):1-6 doi:10.1007/8904_2017_38.

    PMID: 28685490
  16. 16

    Infant with early onset bilateral facial and bulbar weakness: Successful treatment of riboflavin in multiple acyl-CoA dehydrogenase deficiency caused by biallelic nonsense FLAD1 variants.

    Lee YJ, Kim SY, Kim MJ, et al.

    Neuromuscular disorders : NMD 2021; (31(11)):1194-1198 doi:10.1016/j.nmd.2021.07.006.

    PMID: 34454814
  17. 17

    Long-term ketone body therapy of severe multiple acyl-CoA dehydrogenase deficiency: A case report.

    Fischer T, Och U, Marquardt T

    Nutrition (Burbank, Los Angeles County, Calif.) 2019; (60()):122-128 doi:10.1016/j.nut.2018.10.014.

    PMID: 30557775

This page describes nutrition and supplement approaches for MADD for educational purposes only and does not replace individualized medical advice. Work with your metabolic physician and dietitian before changing meals, fasting intervals, or supplements.